This is a China news story, published by Yahoo, that relates primarily to Incepta news.
For more China news, you can click here:
more China newsFor more Incepta news, you can click here:
more Incepta newsFor more drug discoveries news, you can click here:
more drug discoveries newsFor more news from Yahoo, you can click here:
more news from YahooOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
semaglutide drugs. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest blockbuster drugs Ozempic news, semaglutide tablets news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
Incepta PharmaceuticalsReuters
•81% Informative
At least 106,000 packs of semaglutide-based medicines made in Asia by Incepta have been shipped to 12 foreign markets.
At least three of these firms imported the key ingredient from China and at least one of their products was promoted online and in person outside the country of origin.
Some of Incepta 's semaglutide-based drugs have been rejected, destroyed or seized in at least six countries including the U.S. , Britain and Ireland .
Some Chinese companies have been promoting Laos -produced Semagcare tablets in China .
Novo Nordisk's patent is due to expire in 2026 or earlier if it loses legal challenge.
Zhejiang Peptites Biotech supplied at least 25.6 kg of semaglutide, valued about $2.8 million , to Geropharm in 2023 and 2024 .
The Russian company said supply of Semavic is carried out in accordance with a contract and it does not export the finished drug abroad.
Incepta has imported the ingredient from Swiss generic drugmaker Bachem , according to customs data provider.
VR Score
89
Informative language
95
Neutral language
60
Article tone
formal
Language
English
Language complexity
80
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links